BeOne Medicines AG

Healthcare · Biotechnology · Switzerland

Last price 370.33 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 42.11B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients w...